ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
This analytic paper presents the evidence on the potential of acetylsalicylic acid (ASA) for the mortality reduction in patients with cardiovascular disease. The focus is on the “minimal” effective dose of ASA, in terms of its effects on survival. The discussion of the ASA form and dose selection al...
Saved in:
Main Author: | O. V. Averkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2012-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1255 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01) -
Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk
by: F. I. Belyalov, et al.
Published: (2016-09-01) -
Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: results from NHANES 2003 to 2018
by: Guangyu Wang, et al.
Published: (2025-07-01) -
Low apolipoprotein B and LDL-cholesterol are associated with the risk of cardiovascular and all-cause mortality: a prospective cohort
by: Xiaolin Yu, et al.
Published: (2025-12-01) -
Hyperuricemia and hypertension in working-age people: results of a population study
by: S. A. Shalnova, et al.
Published: (2023-12-01)